Loading clinical trials...
Loading clinical trials...
This is a phase 2a clinical trial based on the IDEAL framework to evaluate the safety, feasibility and clinical efficacy of single-port robotic transanal total mesorectal excision (SPr-taTME )surgery....
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
NCT07389863 · Rectal Cancer Patients
NCT06693375 · Healthy Volunteers, Rectal Cancer Patients
NCT03451370 · Elderly Metastatic Colorectal Cancer Patients
NCT07176182 · Rectal Cancer Patients, Rectal Cancer Stage II, and more
NCT07291401 · Rectal Cancer Patients
Huichao Zheng
Chongqing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions